Tango Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
TNGX chart
What traders are saying about $TNGX
Latest postsTango Therapeutics, Inc. news
- Tango Therapeutics, Inc. (TNGX) Discusses Updated Vopimetastat Combination Data and Registration Strategy in Pancreatic Cancer - Slideshow (NASDAQ:TNGX) 2026-10-27
Seeking Alpha ·
- Tango Therapeutics cuts 14% of workforce to focus on clinical cancer programs
The Business Journals ·
- TNGX Stock Falls 16% Despite Positive Pancreatic Cancer Study Data
Yahoo Finance ·
- Phase 1 2 Cancer Trial Results May Change The Case For Tango Therapeutics Stock
Simply Wall Street ·
- Tango Therapeutics added to Analyst Focus List at JPMorgan
TipRanks ·
- Is Tango Therapeutics (TNGX) Undervalued As Phase 3 Plans Follow Strong Trial Data?
Simply Wall Street ·
- Tango Therapeutics, Inc. (TNGX) Options Chain - Yahoo Finance
Yahoo! Finance Canada ·
- Tango Therapeutics Files 8-K on Vopimetostat Phase 1/2 Trial Update
The Clinical Trial Vanguard ·
- Tango Therapeutics Just Improved On This 'Unprecedented' Cancer Drug
Yahoo Finance ·
- How Tango Improved On Revolution's 'Unprecedented' Results
Investor's Business Daily ·
- Tango Therapeutics, Inc. Estimates – NASDAQ:TNGX
TradingView ·
- Wedbush raises Tango Therapeutics stock price target on trial data
Investing.com ·
Tango Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $62.4M | $42.1M | $36.5M | $24.9M |
| Net income | -$101.6M | -$130.3M | -$101.7M | -$108.2M |
| Diluted EPS | $-0.87 | $-1.19 | $-1.08 | $-1.23 |
| Total assets (year end) | $398.7M | $316.5M | $402.6M | $436.5M |
| Cash and equivalents (year end) | $112.3M | $69.5M | $66.4M | $60.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Tango Therapeutics, Inc.
- Ticker
- TNGX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1819133
- Former names
- BCTG Acquisition Corp.
Frequently asked questions
What exchange is Tango Therapeutics, Inc. listed on?
Tango Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TNGX.
What industry is Tango Therapeutics, Inc. in?
Tango Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Tango Therapeutics, Inc. headquartered?
Tango Therapeutics, Inc.'s business address on file with the SEC is in Boston, MA.
When does Tango Therapeutics, Inc.'s fiscal year end?
Tango Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Tango Therapeutics, Inc. report?
Tango Therapeutics, Inc. reported $62.4M in revenue for calendar year 2025, according to its SEC filings.